Cantel Medical Earnings: Everything You Must Know Now
Cantel Medical Corp. (NYSE:CMN) delivered a profit and met Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.
Cantel Medical Corp. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 10% to $0.33 in the quarter versus EPS of $0.30 in the year-earlier quarter.
Revenue: Rose 7.98% to $105 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Cantel Medical Corp. reported adjusted EPS income of $0.33 per share. By that measure, the company missed the mean analyst estimate of $0.33. It beat the average revenue estimate of $104.92 million.
Quoting Management: Andrew Krakauer, Cantel’s President and CEO stated, “We are pleased to have delivered solid financial performance in the third quarter. These positive results confirm the continued success of our three prong approach to growth which includes investing in new product development, sales and marketing programs and acquisitions. Reported earnings would have been $0.02 better if not for the Medical Device Tax which impacted all three months of this quarter.”
Key Stats (on next page)…
Revenue decreased 1.28% from $106.36 million in the previous quarter. EPS decreased 17.5% from $0.40 in the previous quarter.
Looking Forward: Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.33 to a profit $0.35. For the current year, the average estimate has moved up from a profit of $1.37 to a profit of $1.4 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.